Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2005
10/25/2005US6958158 Immune modulation device for use in animals
10/25/2005US6958060 Method for muscle delivery of drugs, nucleic acids and other compounds
10/25/2005CA2329172C Storage stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/25/2005CA2229045C Use of muteins of wild-type cytokines as immunogens
10/25/2005CA2185470C Compositions and methods for vaccines comprising .alpha.-galactosyl epitopes
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097988A1 Bone marrow-relevant cell participating the maintenance and/or repair of tissue
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097151A1 Antioxidant composition and products containing the same
10/20/2005WO2005097104A1 SOLID PHARMACEUTICAL PREPARATION CONTAINING DIBENZ[b,e]OXEPINE DERIVATIVE
10/20/2005WO2005096806A1 Rice plant having vaccine gene transferred thereinto
10/20/2005WO2005096692A2 Crystalline forms of mizolastine, production methods thereof and pharmaceutical compositions containing same
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050235372 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
10/20/2005US20050234248 Method of producing preparations rich in tocotrienol
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234102 Inhibiting the proteolytic activity of cathepsin S, comprising exposing cathepsin S to compounds such as 1-[4-(5-Chloro-1H-indol-3-yl)-piperidin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol
10/20/2005US20050234090 Modulators of chemokine receptor activity
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234060 Pyrrolotriazine kinase inhibitors
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234049 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233941 Pin coated assay
10/20/2005US20050233328 Methods of identifying compounds that modulate protein activity
10/20/2005US20050232951 Low dose haptenized tumor cell and tumor cell extract immunotherapy
10/20/2005US20050232946 Vaccine against microbial pathogens
10/20/2005US20050232943 Antigenic composition of a Pseudomonas aeruginosa protein
10/20/2005US20050232932 Compositions and methods for dendritic cell-based immunotherapy
10/20/2005US20050232907 Use of herpes vectors for tumor therapy
10/20/2005CA2799469A1 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/20/2005CA2563887A1 Mite allergen zen 1
10/20/2005CA2563313A1 Modulation of nkg2d
10/20/2005CA2562223A1 Treatment of autoimmune disorders of the skin with a goat serum obtained from a goat challenged with hiv immunogen
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2561791A1 Non-imidazole heterocyclic compounds
10/20/2005CA2560311A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection
10/19/2005EP1586649A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/19/2005EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586586A2 Peptide and/or proteins and their use for the manufacture of a therapeutic and/or preventive medicament
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586325A1 Drugs containing galectin 9
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1585805A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
10/19/2005EP1585762A1 Means for regulating the expression of human isoforms of ant
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585546A2 Kim-1 antagonists and use to modulate immune system
10/19/2005EP1585545A2 Methods of inducing and maintaining immune tolerance
10/19/2005EP1585543A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway
10/19/2005EP1585515A2 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1585507A2 The use of estrogen receptor alpha modulators for the treatment of multiphe sclerosis
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1423117B1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1354054B1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/19/2005EP1339438B1 Preventing transplant rejection in the eye
10/19/2005EP1339415A4 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
10/19/2005EP1200095B1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances
10/19/2005EP1137946B1 Use of vascular endothelial growth factor (vegf)
10/19/2005EP1000163B1 Pseudomonas exotoxin a-like chimeric immunogens
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685063A Methods and compositions relating to gene silencing
10/19/2005CN1684973A Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
10/19/2005CN1684966A Novel adenine compound and use thereof
10/19/2005CN1684964A Use of and some novel imidazopyridines
10/19/2005CN1684963A Preparation of 1H-imidazo [4, 5-C] quinolin-4-amines via novel 1H-imidazo [4, 5-C] quinolin-4-cyano and 1H-imidazo [4, 5-C] quinolin-4-carboxamide intermediates
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1684948A Cytotoxic agents containing novel potent taxanes and their therapeutic use
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683525A Method for changing IL-2 receptor distribution in T cell film micro area and its use
10/19/2005CN1683006A Heterosides peptide injection liquor for improving animal immunological function
10/19/2005CN1682983A Medicinal composition containing wild jujube seed, lucid ganoderma and ginseng leaf and its preparing process and use
10/19/2005CN1682973A Cepharanthine oral disintegration tablet and its preparing method
10/19/2005CN1682950A Composition containing nucleoside and its preparing method
10/19/2005CN1682811A Strengthening spine and bone pill ofr treating rigid spondylitis
10/19/2005CN1682770A Process for preparing bee glue water solution and use
10/19/2005CN1682769A Trachyostracous mussel extract capable of increasing immunity function
10/19/2005CN1682767A Pearl powder soft capsule
10/19/2005CN1682730A Cepharanthine slow releasing preparation
10/19/2005CN1223675C Anti tumor immunological active cell- DCIC cell, its preparing method and applications
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223595C Triptolide alcohol derivative and its use
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223371C Preparation of effective component from rhodiola crenulate and preparing method
1 ... 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 ... 1172